Summary of findings: Single vs combination intravenous anti‐pseudomonal antibiotic therapy
Adverse events during treatment · adults and children with cystic fibrosis
The review found no eligible studies for this question.
2 findings from 1 review
- Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
- Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 131 participantsLow